Balanced crystalloids versus saline in the intensive care unit: Study protocol for a cluster-randomized, multiple-crossover trial

Trials

Volumn 18, Issue 1, 2017, Pages

  Semler, Matthew W ^a   Self, Wesley H ^a   Wang, Li ^a   Byrne, Daniel W ^a   Wanderer, Jonathan P ^a,b   Ehrenfeld, Jesse M ^a,b   Stollings, Joanna L ^a   Kumar, Avinash B ^a   Hernandez, Antonio ^a   Guillamondegui, Oscar D ^a   May, Addison K ^a   Siew, Edward D ^a   Shaw, Andrew D ^a   Bernard, Gordon R ^a   Rice, Todd W ^a   Casey, Jonathan D ^a   Noto, Michael J ^a   Domenico, Henry J ^a   Hughes, Christopher G ^a   Holcombe, Emily ^a   Gibson, Jayme ^a   Weavind, Lisa ^a   Pretorius, Mias ^a   Costello, William T ^a   Dunlap, Debra F ^a   Rumbaugh, Kelli A ^a   Atchison, Leanne ^a   Sullivan, Mark ^a   Felbinger, Matthew ^a   Knostman, Molly ^a   Hamblin, Susan E ^a   Young, Jason B ^c   Valenzuela, Julie Y ^c   Mulherin, David P ^b   Hargrove, Fred R ^b   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Emergency Medicine ^*  (United States)

^c Department of Surgery   (United States)

Author keywords

Crystalloid; Intravenous fluids; Pragmatic trial; Renal failure; Saline

Indexed keywords

BICARBONATE; CHLORIDE; CREATININE; NITROGEN; POTASSIUM; RINGER LACTATE SOLUTION; SODIUM; SODIUM CHLORIDE; UREA; ACETIC ACID PLUS GLUCONATE SODIUM PLUS MAGNESIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; CRYSTALLOID; ELECTROLYTE; ISOTONIC SOLUTION; PLASMA SUBSTITUTE; RINGER'S LACTATE;

ACUTE KIDNEY FAILURE; ARTICLE; BICARBONATE BLOOD LEVEL; CHLORIDE BLOOD LEVEL; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; CRYSTALLOID; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SODIUM BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; CRITICAL ILLNESS; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MORTALITY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; TENNESSEE; TIME FACTOR; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; CLINICAL PROTOCOLS; CRITICAL ILLNESS; CROSS-OVER STUDIES; ELECTROLYTES; FLUID THERAPY; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; ISOTONIC SOLUTIONS; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN; RISK FACTORS; SODIUM CHLORIDE; TENNESSEE; TIME FACTORS; TREATMENT OUTCOME;

EID: 85015420227     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-1871-1     Document Type: Article

References (32)

1. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14:R185.
2. Yunos NM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2011;39:2419-24.
3. Smith RJ, Reid DA, Delaney EF, Santamaria JD. Fluid therapy using a balanced crystalloid solution and acid-base stability after cardiac surgery. Crit Care Resusc. 2010;12:235-41.
4. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726-35.
5. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-Lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18-24.
6. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566-72.
7. Raghunathan K, Shaw A, Nathanson B, Stürmer T, Brookhart A, Stefan MS, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42:1585-91.
8. Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med. 2014;161:347-55.
9. Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40:1897-905.
10. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012;255:821-9.
11. Sen A, Keener CM, Sileanu FE, Foldes E, Clermont G, Murugan R, et al. Chloride content of fluids used for large-volume resuscitation is associated with reduced survival. Crit Care Med. 2017;45:e146-53.
12. Krajewski ML, Raghunathan K, Paluszkiewicz SM, Schermer CR, Shaw AD. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015;102:24-36.
13. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314:1701-10.
14. Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, et al. Balanced crystalloids versus saline in the intensive care unit: the SALT randomized trial. Am J Respir Crit Care Med. doi: 10.1164/rccm.201607-1345OC.
15. Young P. Saline is the solution for crystalloid resuscitation. Crit Care Med. 2016;44:1538-40.
16. Semler MW, Rice TW. Saline is not the first choice for crystalloid resuscitation fluids. Crit Care Med. 2016;44:1541-4.
17. Dellinger RP. Crystalloids for fluid resuscitation in sepsis: where is the balance? Ann Intern Med. 2014;161:372-3.
18. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
19. Ware JH, Hamel MB. Pragmatic trials-guides to better patient care? N Engl J Med. 2011;364:1685-7.
20. Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA. 2015;313:369-78.
21. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243-51.
22. Lorenzo M, Davis JW, Negin S, Kaups K, Parks S, Brubaker D, et al. Can Ringer's lactate be used safely with blood transfusions? Am J Surg. 1998;175:308-10.
23. Semler MW, Rice TW, Shaw AD, Siew ED, Self WH, Kumar AB, et al. Identification of major adverse kidney events within the electronic health record. J Med Syst. 2016;40:167.
24. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, et al. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012;7:844-50.
25. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.
26. Závada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, et al. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant. 2010;25:3911-8.
27. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2 Suppl:1-138.
28. Parienti JJ, Kuss O. Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies. Contemp Clin Trials. 2007;28:316-23.
29. Turner RM, White IR, Croudace T, PIP Study Group. Analysis of cluster randomized cross-over trial data: a comparison of methods. Stat Med. 2007;26:274-89.
30. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-11.
31. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-56.
32. Weisbord SD, Gallagher M, Kaufman J, Cass A, Parikh CR, Chertow GM, et al. Prevention of contrast-induced AKI: a review of published trials and the design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) trial. Clin J Am Soc Nephrol. 2013;8:1618-31.